Metabolite profiling by UPLC-PDA-ESI/HDMS and antibacterial activity of Memecylon talbotianum Brandis


Pharmacognosy Communications,2016,6,4,225-231.
Published:August 2016
Type:Original Article

Metabolite profiling by UPLC-PDA-ESI/HDMS and antibacterial activity of Memecylon talbotianum Brandis

Tumkur Ramasetty Bharathi1, Shailasree Sekhar2, Kigga Kadappa Sampath Kumara1, Mudalabeedu Chandregowda Madhusudhan1 and Harishchandra Sripathy Prakash1*

1Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysuru–570 006, Karnataka, INDIA.

2Institution of Excellence, Vijnana Bhavana, University of Mysore, Manasagangotri, Mysuru–570 006, Karnataka, INDIA.


Introduction: UPLC based metabolite profiling was employed to evaluate the chemical constituents of Memecylon talbotianum Brandis extract and its antibacterial activity was studied in vitro. Methods: Methanol extracts of M. talbotianum was subjected to UPLC-PDA-ESI/HDMS metabolite profiling. The antibacterial activity was determined against human pathogens through disc diffusion, Minimum inhibitory concentration (MIC), Minimum biofilm inhibitory concentration (MBIC) test as visualized by Alamar blue and confocal laser scanning microscopy. Results: UPLC-PDA-ESI/HDMS analysis identified eighteen metabolites, synapoyl-hexose-formic acid, kaempferol 3-O-feruloylhexosyl rhamnoside, 6-C-arabinosyl-8-C-glucosylapigenin and isorhamnetin-3-O-glycoside-7-O-glycoside as the main constituents for the first time from this plant. A broad spectrum of antibacterial activity against to test human pathogens (MIC=54 mg/ mL; Gram-positive bacteria) causing lysis at 24 h incubation was reported, resulting in nearly a 4 log10 CFU / mL drop in cell viability at 1.6 X MIC (Gram-positive) for this extract. The extract at 2 fold MIC inhibited the bacterial biofilm formation and at 8 x MIC eradicated biofilms. However, a higher concentration of this extract was identified in this study for a similar effect on Gram-negative bacteria. Conclusion: The presence of these compounds could contribute to their in vitro inhibitory activities against pathogenic bacterial strains indicating its potential as medicinal agents in treatment and prevention of diseases of bacterial origin.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.